FDA Peptide Reclassification 2026: What Researchers Want BPC 157 SolXGenix The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Buy BPC 157 Peptide 99%+ Pure BPC 157 for Research Establishing a Robust Quality System in a 503B Outsourcing Facility American Pharmaceutical Review